{"id":791126,"date":"2022-06-02T14:01:03","date_gmt":"2022-06-02T12:01:03","guid":{"rendered":"https:\/\/bebeez.it\/non-categorizzato\/endpoint-health-raises-52-million-in-financing-to-expand-and-progress-precision-immunology-pipeline\/"},"modified":"2023-07-11T10:48:33","modified_gmt":"2023-07-11T08:48:33","slug":"endpoint-health-raises-52-million-in-financing-to-expand-and-progress-precision-immunology-pipeline","status":"publish","type":"post","link":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/endpoint-health-raises-52-million-in-financing-to-expand-and-progress-precision-immunology-pipeline\/","title":{"rendered":"Endpoint Health Raises $52 Million in Financing to Expand and Progress Precision Immunology Pipeline"},"content":{"rendered":"The company plans to submit its first Investigational New Drug (IND) application later this year\n\nPALO ALTO, Calif.--(BUSINESS WIRE)--Endpoint Health, Inc., a Precision-FirstTM therapeutics company dedicated to addressing unmet needs in immune-mediated acute and chronic diseases, today announced the close of $52 million in equity and debt financing. Major institutional investors participating in the Series A round included Mayfield, Humboldt Fund, AME Cloud Ventures, Boom Capital, Alix Ventures, Yaya Capital, Wireframe Ventures, The Venture Collective, HCX Ventures and Global Health Investment Corporation (GHIC).\n\n\n\nProceeds from the financing round will be used to extend the company\u2019s Precision-FirstTM platform and expand its therapeutic<div class=\"leaky_paywall_message_wrap\"><div id=\"leaky_paywall_message\"><a href=\"https:\/\/bebeez.it\/abbonati\/\">Abbonati<\/a> o <a href=\"https:\/\/bebeez.it\/mio-account\/\">Accedi<\/a> per leggere il resto di questo contenuto.<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>The company plans to submit its first Investigational New Drug (IND) application later this year PALO ALTO, Calif.&#8211;(BUSINESS WIRE)&#8211;Endpoint Health, Inc., a Precision-FirstTM therapeutics company dedicated to addressing unmet needs in immune-mediated acute and chronic diseases, today announced the close of $52 million in equity and debt financing. Major institutional investors participating in the Series [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49625],"tags":[],"settori":[],"slider_categorie_and_home_page":[],"class_list":["post-791126","post","type-post","status-publish","format-standard","hentry","category-private-capital-in-north-america"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Endpoint Health Raises $52 Million in Financing to Expand and Progress Precision Immunology Pipeline - BeBeez<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/endpoint-health-raises-52-million-in-financing-to-expand-and-progress-precision-immunology-pipeline\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Endpoint Health Raises $52 Million in Financing to Expand and Progress Precision Immunology Pipeline - BeBeez\" \/>\n<meta property=\"og:description\" content=\"The company plans to submit its first Investigational New Drug (IND) application later this year PALO ALTO, Calif.--(BUSINESS WIRE)--Endpoint Health, Inc., a Precision-FirstTM therapeutics company dedicated to addressing unmet needs in immune-mediated acute and chronic diseases, today announced the close of $52 million in equity and debt financing. Major institutional investors participating in the Series [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/endpoint-health-raises-52-million-in-financing-to-expand-and-progress-precision-immunology-pipeline\/\" \/>\n<meta property=\"og:site_name\" content=\"BeBeez\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-02T12:01:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-11T08:48:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"683\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"olomaster\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"olomaster\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/endpoint-health-raises-52-million-in-financing-to-expand-and-progress-precision-immunology-pipeline\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/endpoint-health-raises-52-million-in-financing-to-expand-and-progress-precision-immunology-pipeline\/\"},\"author\":{\"name\":\"olomaster\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518\"},\"headline\":\"Endpoint Health Raises $52 Million in Financing to Expand and Progress Precision Immunology Pipeline\",\"datePublished\":\"2022-06-02T12:01:03+00:00\",\"dateModified\":\"2023-07-11T08:48:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/endpoint-health-raises-52-million-in-financing-to-expand-and-progress-precision-immunology-pipeline\/\"},\"wordCount\":657,\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"articleSection\":[\"Private capital in North America\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/endpoint-health-raises-52-million-in-financing-to-expand-and-progress-precision-immunology-pipeline\/\",\"url\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/endpoint-health-raises-52-million-in-financing-to-expand-and-progress-precision-immunology-pipeline\/\",\"name\":\"Endpoint Health Raises $52 Million in Financing to Expand and Progress Precision Immunology Pipeline - BeBeez\",\"isPartOf\":{\"@id\":\"https:\/\/15.161.165.86\/#website\"},\"datePublished\":\"2022-06-02T12:01:03+00:00\",\"dateModified\":\"2023-07-11T08:48:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/endpoint-health-raises-52-million-in-financing-to-expand-and-progress-precision-immunology-pipeline\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/endpoint-health-raises-52-million-in-financing-to-expand-and-progress-precision-immunology-pipeline\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/endpoint-health-raises-52-million-in-financing-to-expand-and-progress-precision-immunology-pipeline\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bebeez.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Endpoint Health Raises $52 Million in Financing to Expand and Progress Precision Immunology Pipeline\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/15.161.165.86\/#website\",\"url\":\"https:\/\/15.161.165.86\/\",\"name\":\"BeBeez\",\"description\":\"BeBeez\",\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/15.161.165.86\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/15.161.165.86\/#organization\",\"name\":\"BeBeez\",\"url\":\"https:\/\/15.161.165.86\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"contentUrl\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"width\":309,\"height\":122,\"caption\":\"BeBeez\"},\"image\":{\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518\",\"name\":\"olomaster\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g\",\"caption\":\"olomaster\"},\"url\":\"https:\/\/bebeez.it\/en\/author\/olomaster\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Endpoint Health Raises $52 Million in Financing to Expand and Progress Precision Immunology Pipeline - BeBeez","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/endpoint-health-raises-52-million-in-financing-to-expand-and-progress-precision-immunology-pipeline\/","og_locale":"en_US","og_type":"article","og_title":"Endpoint Health Raises $52 Million in Financing to Expand and Progress Precision Immunology Pipeline - BeBeez","og_description":"The company plans to submit its first Investigational New Drug (IND) application later this year PALO ALTO, Calif.--(BUSINESS WIRE)--Endpoint Health, Inc., a Precision-FirstTM therapeutics company dedicated to addressing unmet needs in immune-mediated acute and chronic diseases, today announced the close of $52 million in equity and debt financing. Major institutional investors participating in the Series [&hellip;]","og_url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/endpoint-health-raises-52-million-in-financing-to-expand-and-progress-precision-immunology-pipeline\/","og_site_name":"BeBeez","article_published_time":"2022-06-02T12:01:03+00:00","article_modified_time":"2023-07-11T08:48:33+00:00","og_image":[{"width":683,"height":242,"url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png","type":"image\/png"}],"author":"olomaster","twitter_card":"summary_large_image","twitter_misc":{"Written by":"olomaster","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/endpoint-health-raises-52-million-in-financing-to-expand-and-progress-precision-immunology-pipeline\/#article","isPartOf":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/endpoint-health-raises-52-million-in-financing-to-expand-and-progress-precision-immunology-pipeline\/"},"author":{"name":"olomaster","@id":"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518"},"headline":"Endpoint Health Raises $52 Million in Financing to Expand and Progress Precision Immunology Pipeline","datePublished":"2022-06-02T12:01:03+00:00","dateModified":"2023-07-11T08:48:33+00:00","mainEntityOfPage":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/endpoint-health-raises-52-million-in-financing-to-expand-and-progress-precision-immunology-pipeline\/"},"wordCount":657,"publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"articleSection":["Private capital in North America"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/endpoint-health-raises-52-million-in-financing-to-expand-and-progress-precision-immunology-pipeline\/","url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/endpoint-health-raises-52-million-in-financing-to-expand-and-progress-precision-immunology-pipeline\/","name":"Endpoint Health Raises $52 Million in Financing to Expand and Progress Precision Immunology Pipeline - BeBeez","isPartOf":{"@id":"https:\/\/15.161.165.86\/#website"},"datePublished":"2022-06-02T12:01:03+00:00","dateModified":"2023-07-11T08:48:33+00:00","breadcrumb":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/endpoint-health-raises-52-million-in-financing-to-expand-and-progress-precision-immunology-pipeline\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bebeez.it\/en\/private-capital-in-north-america\/endpoint-health-raises-52-million-in-financing-to-expand-and-progress-precision-immunology-pipeline\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/endpoint-health-raises-52-million-in-financing-to-expand-and-progress-precision-immunology-pipeline\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bebeez.it\/en\/"},{"@type":"ListItem","position":2,"name":"Endpoint Health Raises $52 Million in Financing to Expand and Progress Precision Immunology Pipeline"}]},{"@type":"WebSite","@id":"https:\/\/15.161.165.86\/#website","url":"https:\/\/15.161.165.86\/","name":"BeBeez","description":"BeBeez","publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/15.161.165.86\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/15.161.165.86\/#organization","name":"BeBeez","url":"https:\/\/15.161.165.86\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/","url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","contentUrl":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","width":309,"height":122,"caption":"BeBeez"},"image":{"@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518","name":"olomaster","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g","caption":"olomaster"},"url":"https:\/\/bebeez.it\/en\/author\/olomaster\/"}]}},"_links":{"self":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/791126","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/comments?post=791126"}],"version-history":[{"count":1,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/791126\/revisions"}],"predecessor-version":[{"id":891503,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/791126\/revisions\/891503"}],"wp:attachment":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/media?parent=791126"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/categories?post=791126"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/tags?post=791126"},{"taxonomy":"settori","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/settori?post=791126"},{"taxonomy":"slider_categorie_and_home_page","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/slider_categorie_and_home_page?post=791126"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}